Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin degludec/liraglutide add-on to sulphonylurea with or without metformin in adults with type 2 diabetes
2012-000140-97Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- May 2012
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Insulin degludec + liraglutide add-on with Placebo add-on (2 arms). Primary endpoint: Change in glycosylated haemoglobin (HbA1c) from baseline. Started May 2012; status: completed.
02
Drugs
insulin degludecliraglutide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2012-000140-97.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000140-97.